blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1645286

EP1645286 - DRUG FOR NERVE REGENERATION [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  23.11.2007
Database last updated on 25.09.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
KYOWA HAKKO KOGYO CO., LTD.
6-1, Ohtemachi 1-chome Chiyoda-ku
Tokyo 100-8185 / JP
[2006/15]
Inventor(s)01 / MORISHITA, Tsuyoshi c/o BioFrontier Laboratories
Kyowa Hakko Kogyo Co.,Ltd. 3-6,Asahi-machi 3-chome
Machida-shi, Tokyo 194-8533 / JP
02 / SAKURADA, Kazuhiro
9-16,Misuzugaoka, Aobaku, Yokohama-shi
Kanagawa 225-0016 / JP
03 / SUZUKI, Keiko BioFrontier Laboratories
Kyowa Hakko Kogyo Co,Ltd. 3-6,Asahi- machi 3-chome
Machida-shi, Tokyo 194-8533 / JP
04 / IKEDA, Shun-ichi 1367-21, Minami-oya
Machida-shi
Tokyo 194-0031 / JP
 [2006/15]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2006/15]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date04728057.316.04.2004
[2006/15]
WO2004JP05503
Priority number, dateJP2003011457918.04.2003         Original published format: JP 2003114579
[2006/15]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004091663
Date:28.10.2004
Language:EN
[2004/44]
Type: A1 Application with search report 
No.:EP1645286
Date:12.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 28.10.2004 takes the place of the publication of the European patent application.
[2006/15]
Search report(s)International search report - published on:JP28.10.2004
ClassificationIPC:A61K45/00, A61K31/404, A61K31/4045, A61K31/407, A61K31/553, C07D403/04, C07D403/14, C07D498/22, A61P25/28, A61P25/08, A61P25/22, A61P25/18, A61P25/24, C07D487/14
[2006/15]
CPC:
A61K31/00 (EP,US); A61K31/404 (EP,US); A61K31/4045 (EP,US);
A61K31/407 (EP,US); A61K31/553 (EP,US); A61P25/00 (EP);
A61P25/08 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P43/00 (EP); A61P9/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/15]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:ARZNEIMITTEL ZUR NERVENREGENERATION[2006/15]
English:DRUG FOR NERVE REGENERATION[2006/15]
French:MEDICAMENT POUR LA REGENERATION DES NERFS[2006/15]
Entry into regional phase16.11.2005Translation filed 
16.11.2005National basic fee paid 
16.11.2005Search fee paid 
16.11.2005Designation fee(s) paid 
16.11.2005Examination fee paid 
Examination procedure16.11.2005Amendment by applicant (claims and/or description)
16.11.2005Examination requested  [2006/15]
15.11.2007Application withdrawn by applicant  [2007/52]
Fees paidRenewal fee
30.03.2006Renewal fee patent year 03
27.04.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]JPH02306974  (GOEDECKE AG);
 [X]JPH07508268  ;
 [X]WO9942100  (SAGAMI CHEM RES [JP], et al);
 [X]WO0038675  (SMITHKLINE BEECHAM PLC [GB], et al);
 [X]WO0113916  (SAGAMI CHEM RES [JP], et al);
 [X]WO0137819  (CENTRE NAT RECH SCIENT [FR], et al);
 [X]WO02062387  (SMITHKLINE BEECHAM PLC [GB], et al);
 [X]  - LEOST M. ET AL, "Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25", EUR. J. BIOCHEM., (2000), vol. 267, pages 5983 - 5994, XP000981256

DOI:   http://dx.doi.org/10.1046/j.1432-1327.2000.01673.x
 [X]  - CHEN G. ET AL, "Enhancement of Hippocampal Neurogenesis by Lithium", JOURNAL OF NEUROCHEMISTRY, (2000), vol. 75, pages 1729 - 1734, XP002951304

DOI:   http://dx.doi.org/10.1046/j.1471-4159.2000.0751729.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.